On May 23, PIPC submitted a comment letter to the Colorado Prescription Drug Affordability Board (PDAB) on the Board's ongoing process for affordability reviews and establishment of upper payment limits.
|
PIPC submitted a letter to the Oregon Prescription Drug Affordability Board (PDAB) on the Board's ongoing affordability review activities.
On May 13, PIPC submitted a comment letter to the Maryland Prescription Drug Affordability Board (PDAB) on the Board's ongoing Cost Review Study process.
On May 7, PIPC submitted comments on the Institute for Clinical and Economic Review's (ICER) assessment of chronic obstructive pulmonary disease (COPD).
|
